BAG Healthcare GmbH is split into BAG Healthcare GmbH, BAG Diagnostics GmbH & BAG Holding GmbH. Together they form the BAG Group.
R&D department is established in the field of molecular genetic diagnostics
Market launch of the first fully automated SSO-based molecular genetic analysis system ("Mr. Spot")
Corporate identity is relaunched and renamed BAG Health Care GmbH
2004-2008: Building extensions in the area of pharmaceutical contract manufacturing: The freeze-drying capacities are quadrupled.
Dr. med. Nicolas Sachsenberg takes over the management in the 3rd generation
Entry into nucleic acid diagnostics
New logo is introduced
Renaming of Biologische Arbeitsgemeinschaft GmbH to Biologisches Analysensystem GmbH
Start of HLA production
Entry of Hannover Finanz as first and long-standing private equity partner
Second Logo - Renaming to Biologische Analysensystem GmbH
Introduction of biochemical technologies for the detection of bacteria and fungi
Margaretha Sachsenberg joins the company management
Set-up service organisation of diagnostics for hospital laboratories
The former Lich Municipal Hospital for diagnostics and pharmaceutical production is leased
Beginning of made-to-order production of injectables for pharmaceutical companies
Klaus J. Sachsenberg takes over the management. Biologische Arbeitsgemeinschaft GmbH is restructured to a manufacturing company
1949 - 1973: Professor Walter Menk, Scientific Director of the BAG
First logo - Biologische Arbeitsgemeinschaft GmbH
BAG founded by Gotthard Sachsenberg and first laboratory in the old Lich Castle - small-scale penicillin production